fbpx

Latest news

Personalized Dosing – It’s here, but how do we do it?
17 Feb 2017 | Blog

Personalized Dosing – It’s here, but how do we do it?

Dosing medicines correctly is challenging, and varies depending upon which methods or algorithms are chosen by each healthcare practitioner. We require a personalized dose as every individual absorbs and clears medicines at different rates. If everyone takes the same medicine dose, some will end up with unwanted side effects, while...

Read more
DoseMe Partners with Microsoft
13 Dec 2016 | Company Statement

DoseMe Partners with Microsoft

DoseMe will continue a strong relationship with Microsoft by transitioning to the Microsoft Azure cloud based web server. As a large user of cloud-based servers a reliable software platform is fundamental to ensuring the consistency of the DoseMe platform offering. Our decision to build and deliver solutions based on...

Read more
Delivering Precision Dosing to Australian Cancer Patients
10 Nov 2016 | Media Release

Delivering Precision Dosing to Australian Cancer Patients

DoseMe partners with Charm Health to improve management of high risk oncology medicines and deliver precision dosing to Australian cancer patients. Today DoseMe announced a strategic alliance with specialist oncology eHealth provider, Charm Health, to integrate its personalised dosing tool with the CHARM™ platform. This will provide clinicians using CHARM...

Read more
DoseMe completes Series A financing, eyes global expansion
25 Aug 2016 | Media Release

DoseMe completes Series A financing, eyes global expansion

DoseMe, a privately held digital medical solutions provider, today announced it closed a $2.6 million Series A financing round, valuing the company at $20 million. The funding was secured from two veteran healthcare executives, Greg Spurgin and Gary Cunningham, both founders of leading US outpatient orthopaedic physical therapy company Results...

Read more
New vancomycin obese & hemodialysis models released!Check it out →
+

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.